Several medications now calm painful inflammation in the intestines. Diets free of ultraprocessed foods also help ...

With another inflammatory bowel disease (IBD) approval in the bag for Tremfya, Johnson & Johnson continues to make good on ...

The trial’s primary objective is to assess PALI-2108’s tolerability, pharmacokinetics and safety in healthy volunteers.

Ulcerative colitis (UC) is one of the two major types of chronic inflammatory bowel diseases (IBD), along with Crohn’s disease. UC affects the large bowel, has no known cure, and requires lifelong ...

JNJ's ulcerative colitis drug shows promise in mid-stage trials, with high response rates and well-tolerated safety profile ...

Ulcerative colitis is a condition that causes ulcers and inflammation to develop on the inner lining of the large intestine. Some people may also develop inflammation in other areas, such as the ...

They include: having a family history of ulcerative colitis having a history of gastroenteritis having a history of smoking cigarettes living in an urban environment using certain medications ...

Drinking two small glasses of cherry juice daily may help reduce gut inflammation and improve the quality of life for people ...

The top 10 projected best-selling medications in 2026, including GLP-1 drugs and AbbVie's Skyrizi, have expected global sales reaching up to $31 billiion.

"Palisade Bio begins dosing subjects in last cohort of ulcerative colitis drug trial" was originally created and published by Clinical Trials Arena, a GlobalData owned brand. The information on ...